 |
|
 |
 |
Premium News Article
Northfield Labs Pulls Plug on Blood Substitute Operations in Illinois
SUGAR LAND--May 12, 2009--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In a virtual bloodbath, Northfield Laboratories (NASDAQ:NFLD) (Evanston, Illinois) issued a statement on May 8, announcing "that it has terminated the employment of substantially all of its operational and staff employees at its manufacturing facility in Mount Prospect, Illinois and headquarters in Evanston, Illinois." The action follows the Food and Drug Administration's (FDA) recent rejection of the company's Biologics License Application for PolyHeme, a human hemoglobin-based, oxygen-carrying red blood cell substitute.
Read the Complete Article >>>
Details on this Article:
Industry Segment: Pharmaceutical & Biotech
Word Count: 640 Words
| Login or Register now for instant access! |
 |
Related Articles
Value of Industrial Project Starts in North America at $150 Billion for 200...

Industrial Info's World Expansion Helps Clients Uncover New Business Opport...

Project Management Excellence Promotes Project Success, by Pathfinder LLC, ...

Weird Science? Big Pharma's Top Three M&A Deals in 2009 Nears $160 Billion

Baltimore's Cel-Sci to Begin Production in $22 Million Aseptic Biopharma Pl...

|
|
 |
 |
|
 |
|
 |


This article is available for Premium Members only.
Subscribe Now! All Fields are Required...
Upgrade your Premium News Subscription to include all archived articles for only $160. Contact Member Services: 800-762-3361
All Members Receive the Following Free Resources:
North American Project & Gap Spending
North American Plant Analysis by Industry & Market Region
Market Maps & Stats - Capital & Maintenance Activity
Current & Historic Economic Indicators
30/60/90 Day Weather Forecast
|